These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 33687462)
1. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US. Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462 [TBL] [Abstract][Full Text] [Related]
2. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020. Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395 [TBL] [Abstract][Full Text] [Related]
3. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States. Gerlach LB; Olfson M; Kales HC; Maust DT J Am Geriatr Soc; 2017 Sep; 65(9):2052-2056. PubMed ID: 28467623 [TBL] [Abstract][Full Text] [Related]
4. The Association Between Central Nervous System-Active Medication Use and Fall-Related Injury in Community-Dwelling Older Adults with Dementia. Hart LA; Marcum ZA; Gray SL; Walker RL; Crane PK; Larson EB Pharmacotherapy; 2019 May; 39(5):530-543. PubMed ID: 30861179 [TBL] [Abstract][Full Text] [Related]
5. Medication Costs and Use of Older Americans in Assisted Living Settings: a Nationally Representative Cross-Sectional Study. Lei L; Samus QM; Thomas KS; Maust DT J Gen Intern Med; 2023 Feb; 38(2):294-301. PubMed ID: 35132546 [TBL] [Abstract][Full Text] [Related]
6. Trends in central nervous system-active polypharmacy among people with multiple sclerosis. Naizer H; Wozny J; Krause TM; Huson E; Freeman L Mult Scler; 2024 Aug; 30(9):1139-1150. PubMed ID: 38751229 [TBL] [Abstract][Full Text] [Related]
7. Changes in the Use of Long-Term Medications Following Incident Dementia Diagnosis. Anderson TS; Ayanian JZ; Curto VE; Politzer E; Souza J; Zaslavsky AM; Landon BE JAMA Intern Med; 2023 Oct; 183(10):1098-1108. PubMed ID: 37603340 [TBL] [Abstract][Full Text] [Related]
8. Central Nervous System-Active Prescriptions in Older Veterans: Trends in Prevalence, Prescribers, and High-risk Populations. Burke RE; Pelcher L; Tjader A; Linsky AM; Thorpe CT; Turner JP; Rose L J Gen Intern Med; 2023 Dec; 38(16):3509-3516. PubMed ID: 37349639 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and trend of central nervous system-active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study. Wei YJ; Shrestha N; Chiang C; DeKosky ST Alzheimers Res Ther; 2024 Feb; 16(1):30. PubMed ID: 38326897 [TBL] [Abstract][Full Text] [Related]
10. New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge. Growdon ME; Gan S; Yaffe K; Lee AK; Anderson TS; Muench U; Boscardin WJ; Steinman MA J Am Geriatr Soc; 2023 Apr; 71(4):1134-1144. PubMed ID: 36514208 [TBL] [Abstract][Full Text] [Related]
11. Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults. Musich S; Wang SS; Slindee LB; Ruiz J; Yeh CS Popul Health Manag; 2020 Aug; 23(4):286-296. PubMed ID: 31765280 [TBL] [Abstract][Full Text] [Related]
12. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study. Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416 [TBL] [Abstract][Full Text] [Related]
13. High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period. Fick D; Kolanowski A; Waller J Aging Ment Health; 2007 Sep; 11(5):588-95. PubMed ID: 17882597 [TBL] [Abstract][Full Text] [Related]
14. Medication misuse and overuse in community-dwelling persons with dementia. Deardorff WJ; Jing B; Growdon ME; Yaffe K; Boscardin WJ; Boockvar KS; Steinman MA J Am Geriatr Soc; 2023 Oct; 71(10):3086-3098. PubMed ID: 37272899 [TBL] [Abstract][Full Text] [Related]
15. An investigation of psychoactive polypharmacy and related gender-differences in older adults with dementia: a retrospective cohort study. Trenaman SC; Quach J; Bowles SK; Kirkland S; Andrew MK BMC Geriatr; 2023 Oct; 23(1):683. PubMed ID: 37864154 [TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapeutic management of dementia across settings of care. Rattinger GB; Burcu M; Dutcher SK; Chhabra PT; Rosenberg PB; Simoni-Wastila L; Franey CS; Walker LD; Zuckerman IH J Am Geriatr Soc; 2013 May; 61(5):723-33. PubMed ID: 23590231 [TBL] [Abstract][Full Text] [Related]
17. Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia. Lau DT; Mercaldo ND; Shega JW; Rademaker A; Weintraub S Am J Alzheimers Dis Other Demen; 2011 Dec; 26(8):606-15. PubMed ID: 22207646 [TBL] [Abstract][Full Text] [Related]
18. Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia. Bae-Shaaw YH; Shier V; Sood N; Seabury SA; Joyce G J Alzheimers Dis; 2023; 93(2):471-481. PubMed ID: 37038818 [TBL] [Abstract][Full Text] [Related]
19. Central nervous system (CNS) medications and polypharmacy in later life: cross-sectional analysis of the English Longitudinal Study of Ageing (ELSA). Slater N; White S; Frisher M BMJ Open; 2020 Sep; 10(9):e034346. PubMed ID: 32928845 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of potentially inappropriate prescribing of central nervous system and psychotropic drugs among elderly patients: A national population study in Korea. Cho H; Choi J; Kim YS; Son SJ; Lee KS; Hwang HJ; Kang HY Arch Gerontol Geriatr; 2018 Jan; 74():1-8. PubMed ID: 28917110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]